Lexicon Pharmaceuticals, Inc.

10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure May 6, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Shareholder vote results Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Feb 2, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 29, 2026 8-K Other events Nov 10, 2025 8-K Other events Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Other events Jul 28, 2025 8-K Other events Jul 3, 2025 8-K Entered a material agreement; Shareholder vote results Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Entered a material agreement Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 7, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Delisting notice or listing-rule failure Jan 7, 2025 8-K Director or officer change Jan 2, 2025 8-K Exit or disposal costs Nov 22, 2024 8-K Director or officer change Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement Oct 16, 2024 8-K Director or officer change Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 2, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change Jul 8, 2024 8-K Entered a material agreement Jul 1, 2024 8-K Unregistered sale of equity; Amended charter or bylaws; Shareholder vote results May 10, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Director or officer change Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 25, 2024 8-K Modified rights of security holders; Amended charter or bylaws Mar 12, 2024